Lopuskin: Stock prices have deviated significantly for two consecutive days, with the cumulative deviation exceeding 20%, indicating abnormal volatility.

Lubcekin announced that the company's stock had deviated by more than 20% from the closing price for two consecutive trading days on November 4th and November 5th, 2025, which constituted abnormal stock trading fluctuations. The company's investigation found that there was no need to correct or supplement the information previously disclosed, and no undisclosed significant information that could affect the stock price was found in public media reports. The company's operations and internal and external environment are normal recently, and the controlling shareholder and ultimate controller have not disclosed any undisclosed significant matters. During the abnormal fluctuations, the company did not buy or sell its own stock. The company reminds investors to rely on information disclosed through designated media outlets and to invest rationally.